Ten years of development at TNO has yielded a track record and acceptance by regulators of the biomedical accelerator mass spectrometry (AMS) technology. TNO aims to boost the technology’s market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback